• Boris Draznin, Janice Gilden, Sherita H Golden, Silvio E Inzucchi, PRIDE investigators, David Baldwin, Bruce W Bode, Jeffrey B Boord, Susan S Braithwaite, Enrico Cagliero, Kathleen M Dungan, Mercedes Falciglia, M Kathleen Figaro, Irl B Hirsch, David Klonoff, Mary T Korytkowski, Mikhail Kosiborod, Lillian F Lien, Michelle F Magee, Umesh Masharani, Gregory Maynard, Marie E McDonnell, Eti S Moghissi, Neda Rasouli, Daniel J Rubin, Robert J Rushakoff, Archana R Sadhu, Stanley Schwartz, Jane Jeffrie Seley, Guillermo E Umpierrez, Robert A Vigersky, Cecilia C Low, and Deborah J Wexler.
• Division of Endocrinology, Diabetes and Metabolism, University of Colorado School of Medicine, Aurora, Colorado, USA. boris.draznin@ucdenver.edu
• Diabetes Care. 2013 Jul 1; 36 (7): 1807-14.

AbstractCurrently patients with diabetes comprise up to 25-30% of the census of adult wards and critical care units in our hospitals. Although evidence suggests that avoidance of hyperglycemia (>180 mg/dL) and hypoglycemia (<70 mg/dL) is beneficial for positive outcomes in the hospitalized patient, much of this evidence remains controversial and at times somewhat contradictory. We have recently formed a consortium for Planning Research in Inpatient Diabetes (PRIDE) with the goal of promoting clinical research in the area of management of hyperglycemia and diabetes in the hospital. In this article, we outline eight aspects of inpatient glucose management in which randomized clinical trials are needed. We refer to four as system-based issues and four as patient-based issues. We urge further progress in the science of inpatient diabetes management. We hope this call to action is supported by the American Diabetes Association, The Endocrine Society, the American Association of Clinical Endocrinologists, the American Heart Association, the European Association for the Study of Diabetes, the International Diabetes Federation, and the Society of Hospital Medicine. Appropriate federal research funding in this area will help ensure high-quality investigations, the results of which will advance the field. Future clinical trials will allow practitioners to develop optimal approaches for the management of hyperglycemia in the hospitalized patient and lessen the economic and human burden of poor glycemic control and its associated complications and comorbidities in the inpatient setting.

13 keywords...

hide…